Complications and Functional Results of Surgery for Locally Advanced Prostate Cancer

Abstract EN

The role of surgery in clinical stage T3 prostate cancer (cT3 PCa) is still subject to debate.

We reviewed the records of 139 consecutive patients who underwent a radical prostatectomy (RP) for cT3 PCa with a mean follow-up of 8 years.

All data related to surgical and perioperative complications were collected.

Continence and erectile function were assessed at 12 months postoperatively and long-term oncologic outcomes were analyzed.

Rectal injury and injury of the obturator nerve occurred both in 0.7% of cases.

No serious in-hospital complications were noted and no reintervention was needed.

Lymphatic leakage was noted in 2.2% of patients and 1.4% experienced prolonged drainage of urine.

In 7.2%, wound-related problems occurred.

Anastomotic stricture occurred in 2.9%.

These complication rates were not different compared to surgical series of RP in localized PCa.

At 12 months, complete continence was 87.8% and erectile function had fully recovered in 6% and 10% of patients who underwent a non-nerve sparing or unilateral nerve-sparing procedure, respectively.

10-year estimated biochemical PFS, clinical PFS, CSS and OS were 51.8%, 85.6%, 94.6% and 85.9%, respectively.

In cT3 PCa, RP is technically feasible with morbidity comparable to RP in clinically localized PCa.

Long-term oncologic control was excellent.